Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Eli Lilly and Company (LLY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 93,413,000
  • Shares Outstanding, K 1,103,390
  • Annual Sales, $ 21,222 M
  • Annual Income, $ 2,738 M
  • 36-Month Beta 0.35
  • Price/Sales 4.41
  • Price/Cash Flow 17.88
  • Price/Book 6.63

Price Performance

See More
Period Period Low Period High Performance
1-Month
81.37 +4.14%
on 07/06/17
85.53 -0.92%
on 07/24/17
+0.85 (+1.01%)
since 06/23/17
3-Month
76.85 +10.27%
on 05/22/17
85.53 -0.92%
on 07/24/17
+1.32 (+1.58%)
since 04/24/17
52-Week
64.18 +32.03%
on 11/23/16
86.72 -2.28%
on 04/05/17
+3.15 (+3.86%)
since 07/22/16

Most Recent Stories

More News
Accelerator Corporation Announces Series A Financing in Rodeo Therapeutics to Focus on Small-Molecule Regenerative Therapies

Accelerator Corporation, a leading life science investment and management firm, today announced a $5.9 million Series A financing in Rodeo Therapeutics Corporation, a company developing...

JNJ : 133.01 (-1.70%)
LLY : 84.74 (+0.09%)
CGIX : 3.80 (-1.30%)
Hasbro and Hibbett sink as WebMD and Nektar climb

NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday:

HIBB : 13.10 (-33.50%)
CALM : 34.85 (-6.06%)
LLY : 84.74 (+0.09%)
SGMS : 34.15 (+27.19%)
ITW : 141.98 (-3.61%)
Big Pharma Q2 Earnings Releases on Jul 25: LLY, BIIB, AMGN

Three pharma giants are set to report second-quarter results on Jul 25. Let's see how things are shaping up for this quarter.

JNJ : 133.01 (-1.70%)
LLY : 84.74 (+0.09%)
NVS : 84.29 (-0.82%)
AMGN : 181.06 (+0.47%)
BIIB : 284.70 (+0.63%)
Merck's Biosimilar Insulin Gets Tentative FDA Approval

Merck (MRK) secures a tentative FDA approval for its insulin candidate, Lusduna Nexvue, a biosimilar version of Sanofi's Lantus. The sanction is provisional owing to an ongoing litigation with Sanofi.

MRK : 62.57 (-0.10%)
LLY : 84.74 (+0.09%)
PFE : 33.32 (-0.48%)
SNY : 47.71 (unch)
Pharma Stock Roundup: J&J, NVS' Q2 Earnings, Merck Drug Gets Tentative FDA Nod

Pharma sector second quarter earnings season has started with industry bellwether Johnson & Johnson (JNJ) reporting earlier this week while AstraZeneca and Merck provided regulatory updates.

AZN : 33.85 (-0.59%)
JNJ : 133.01 (-1.70%)
MRK : 62.57 (-0.10%)
LLY : 84.74 (+0.09%)
NVS : 84.29 (-0.82%)
SNY : 47.71 (unch)
BMY : 55.60 (-0.09%)
Can Biogen (BIIB) Keep the Earnings Streak Alive in Q2?

At Biogen's (BIIB) Q2 call, investor focus will remain on Tecfidera's scrip trends, pipeline progress and acquisition plans. All eyes will also be on Spinraza's performance in Q2.

LLY : 84.74 (+0.09%)
ABBV : 73.91 (-0.96%)
PFE : 33.32 (-0.48%)
BIIB : 284.70 (+0.63%)
Is a Beat in the Cards for Eli Lilly (LLY) in Q2 Earnings?

Eli Lilly and Company's (LLY) new drugs like Trulicity, Cyramza, Taltz and Jardiance have been performing well. Let's see if these along with its older products lead the company to an earnings beat.

NVO : 41.90 (-2.44%)
LLY : 84.74 (+0.09%)
PFE : 33.32 (-0.48%)
SNY : 47.71 (unch)
Why Did Radius Health (RDUS) Stock Plummet Today?

Shares of Radius Health (RDUS) dropped more than 7.8% in early morning trading hours Monday after the company announced that Jesper Hoiland, a former top-ranking executive at Novo Nordisk (NVO), has been...

NVO : 41.90 (-2.44%)
RDUS : 43.24 (+2.42%)
LLY : 84.74 (+0.09%)
AMGN : 181.06 (+0.47%)
Pharma Stock Roundup: FDA Panel Votes for Novartis CAR-T Drug, SNY to Buy Vaccines Co.

Novartis (NVS) was in the limelight this week with its CAR-T cell therapy receiving the support of an FDA advisory panel.

MYL : 38.76 (-1.05%)
AZN : 33.85 (-0.59%)
JNJ : 133.01 (-1.70%)
LLY : 84.74 (+0.09%)
NVS : 84.29 (-0.82%)
PFE : 33.32 (-0.48%)
SNY : 47.71 (unch)
Can ImmunoGen's Lead Pipeline Cancer Candidate Boost Growth?

On Jul 12, 2017, we issued an updated report on ImmunoGen, Inc. (IMGN).

LLY : 84.74 (+0.09%)
IMGN : 6.34 (+12.01%)
NVS : 84.29 (-0.82%)
AMGN : 181.06 (+0.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

Eli Lilly and Company discovers, develops, manufactures, and sells products in one significant business segment -pharmaceutical products. The company directs its research efforts primarily toward the search for products to diagnose, prevent and treat human diseases. The company also conducts research...

See More

Support & Resistance

2nd Resistance Point 85.95
1st Resistance Point 85.34
Last Price 84.74
1st Support Level 84.32
2nd Support Level 83.91

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.